Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ETFDH |
| Upstream (Parents) |
|---|
| (<<) TTPA → ETFDH |
| (<<) HMGCL → ETFDH |
| Downstream (Children) |
|---|
| ETFDH → BLNK (>>) |
| ETFDH → GGT1 (>>) |
| ETFDH → HMGCS2 (>>) |
| ETFDH → LOC29034 (>>) |
| ETFDH → PDK4 (>>) |
| ETFDH → AVPR1A (>>) |
| ETFDH → ADRA1B (>>) |
| ETFDH → TFPI (>>) |
| ETFDH → EPHX2 (>>) |
| ETFDH → CTH (>>) |
| ETFDH → CA14 (>>) |
| ETFDH → ACSM3 (>>) |
| ETFDH → SLC23A2 (>>) |
| ETFDH → TNK1 (>>) |
| ETFDH → KIAA0922 (>>) |
| ETFDH → HMGCL (>>) |
| ETFDH → SLC25A36 (>>) |
| ETFDH → RORC (>>) |
| ETFDH → ZNF512B (>>) |
| ETFDH → RAB27A (>>) |
| ETFDH → POR (>>) |
| ETFDH → OXTR (>>) |
| ETFDH → AFP (>>) |
| ETFDH → EFNB2 (>>) |
| ETFDH → HSDL2 (>>) |
| ETFDH → LMAN1 (>>) |
| ETFDH → FH (>>) |
| ETFDH → CPT2 (>>) |
| ETFDH → AGL (>>) |
| ETFDH → ARID5A (>>) |
| ETFDH → SCCPDH (>>) |
| ETFDH → C21orf33 (>>) |
| ETFDH → LPCAT3 (>>) |
| ETFDH → CPEB3 (>>) |
